terazosin-treated patients had significantly greater decreases in mean percent change of total cholesterol ( -4.8 % ) and low-density lipoprotein plus very-low-density lipoprotein cholesterol ( -6.3 % ) levels , compared with the placebo-treated patients ( +0.6 % and +1.1 % , respectively ) .
C0008377
cholesterol
C0023826
very-low-density lipoprotein